MAPT and Parkinson disease: In a pooled sample of PD patients, both CSF T-Tau and Aβ levels have been cross-sectionally associated with lateral ventricular size (Beyer et al., 2013), whereas there are only limited studies investigating the involvement of CSF markers and progressive atrophy in PD (Compta et al., 2013).